Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort
Objective. Data from trials demonstrated that abatacept (ABA) has a good safety and efficacy profile in treating rheumatoid arthritis. We have studied the retention rate of ABA in a real-life cohort of patients with rheumatoid arthritis. Methods. This is a monocentric, retrospective study including...
Saved in:
Main Authors: | E. Molteni (Author), C. Pirone (Author), F. Ceccarelli (Author), C. Castellani (Author), C. Alessandri (Author), M. Di Franco (Author), V. Riccieri (Author), F.R. Spinelli (Author), R. Priori (Author), R. Scrivo (Author), F. Conti (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors
by: C. Garufi, et al.
Published: (2024) -
Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature
by: M. Di Franco, et al.
Published: (2011) -
Usefulness of anti-cyclic citrullinate peptide antibody determination in synovial fluid analysis of patients with rheumatoid arthritis
by: G. Valesini, et al.
Published: (2011) -
Cost-minimization analysis of subcutaneous abatacept in the treatment of rheumatoid arthritis in Spain
by: R. Ariza, et al.
Published: (2014) -
EXPERIENCE OF TREATMENT WITH ABATACEPT IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS
by: Ye. I. Alekseyeva, et al.
Published: (2011)